Consolidated Statements of Cash Flows

(Millions of yen)

Fiscal year ended

March 31, 2024

Fiscal year ended

March 31, 2025

Cash flows from operating activities

Profit before income taxes

9,862

6,192

Depreciation

2,662

2,247

Impairment losses

300

Increase (decrease) in retirement benefit asset and liability

(5,262)

231

Interest and dividend income

(335)

(293)

Interest expenses

40

51

Foreign exchange losses (gains)

15

97

Share of loss (profit) of entities accounted for using equity method

41

53

Loss (gain) on sale and retirement of property, plant and equipment

2

0

Loss (gain) on sale of investment securities

(3,340)

(127)

Decrease (increase) in trade receivables

(370)

1,203

Decrease (increase) in inventories

(2,713)

(2,675)

Increase (decrease) in trade payables

1,494

339

Loss (gain) on step acquisitions

(1,257)

Other, net

626

(180)

Subtotal

2,724

6,183

Interest and dividends received

414

379

Interest paid

(41)

(51)

Income taxes paid

(1,611)

(4,026)

Net cash provided by (used in) operating activities

1,486

2,485

Cash flows from investing activities

Proceeds from redemption of securities

400

500

Purchase of securities

(500)

Purchase of property, plant and equipment

(1,320)

(2,960)

Proceeds from sale of property, plant and equipment

1

0

Purchase of intangible assets

(133)

(602)

Purchase of investment securities

(352)

Proceeds from sale of investment securities

4,230

252

Purchase of shares of subsidiaries and associates

(1,464)

Purchase of shares of subsidiaries resulting in change in scope of consolidation

(2,189)

Other, net

845

(1,125)

Net cash provided by (used in) investing activities

1,706

(6,124)

Cash flows from financing activities

Proceeds from long-term borrowings

3,000

Repayments of long-term borrowings

(3,138)

(4,680)

Net decrease (increase) in treasury shares

9

(0)

Dividends paid

(792)

(1,275)

Other, net

(22)

Net cash provided by (used in) financing activities

(3,943)

(2,956)

Effect of exchange rate change on cash and cash equivalents

(15)

(97)

Net increase (decrease) in cash and cash equivalents

(766)

(6,692)

Cash and cash equivalents at beginning of period

17,505

16,738

Increase in cash and cash equivalents resulting from inclusion of subsidiaries in consolidation

556

Cash and cash equivalents at end of period

16,738

10,603